AU1873783A - Creación de Inventos y Patentes con Inteligencia Artificial

AU1873783A – Constant release formulation
– Google Patents

AU1873783A – Constant release formulation
– Google Patents
Constant release formulation

Info

Publication number
AU1873783A

AU1873783A
AU18737/83A
AU1873783A
AU1873783A
AU 1873783 A
AU1873783 A
AU 1873783A
AU 18737/83 A
AU18737/83 A
AU 18737/83A
AU 1873783 A
AU1873783 A
AU 1873783A
AU 1873783 A
AU1873783 A
AU 1873783A
Authority
AU
Australia
Prior art keywords
release formulation
constant release
constant
formulation
release
Prior art date
1982-10-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AU18737/83A
Inventor
James Michael Dunn
Ronald Thomas Haas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Verex Laboratories Inc

Original Assignee
Verex Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1982-10-08
Filing date
1983-09-06
Publication date
1984-04-12

1983-09-06
Application filed by Verex Laboratories Inc
filed
Critical
Verex Laboratories Inc

1984-04-12
Publication of AU1873783A
publication
Critical
patent/AU1873783A/en

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/20—Pills, tablets, discs, rods

A61K9/2004—Excipients; Inactive ingredients

AU18737/83A
1982-10-08
1983-09-06
Constant release formulation

Abandoned

AU1873783A
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US43339782A

1982-10-08
1982-10-08

US433397

1982-10-08

Publications (1)

Publication Number
Publication Date

AU1873783A
true

AU1873783A
(en)

1984-04-12

Family
ID=23720002
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU18737/83A
Abandoned

AU1873783A
(en)

1982-10-08
1983-09-06
Constant release formulation

Country Status (3)

Country
Link

EP
(1)

EP0108218A3
(en)

AU
(1)

AU1873783A
(en)

ZA
(1)

ZA836627B
(en)

Cited By (4)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU581177B2
(en)

1983-05-31
1989-02-16
Choong-Gook Jang
Dry direct compression compositions for controlled release dosage forms

AU588630B2
(en)

1985-10-11
1989-09-21
Aktiebolaget Hassle
Pharmaceutical preparation with controlled release of metoprolol

AU597952B2
(en)

1986-04-17
1990-06-14
Alza Corporation
Chlorpheniramine therapy

US6022498A
(en)

1996-04-19
2000-02-08
Q2100, Inc.
Methods for eyeglass lens curing using ultraviolet light

Families Citing this family (27)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE3333639A1
(en)

1983-09-17
1985-03-28
Dynamit Nobel Ag

PREPARATION OF NITROESTERS FOR CORONARY THERAPY

US4765985A
(en)

1985-03-05
1988-08-23
Ciba-Geigy Corporation
Devices and methods for treating memory impairment

US4680172A
(en)

1985-03-05
1987-07-14
Ciba-Geigy Corporation
Devices and methods for treating memory impairment

EP0452334A4
(en)

1989-10-31
1991-12-11
Watson Laboratoires, Inc.
Mucoadhesive carrier for delivery of therapeutical agent

DE4127665A1
(en)

1991-08-22
1993-02-25
Beiersdorf Ag

GALENIC MATRIX

GB2284760B
(en)

1993-11-23
1998-06-24
Euro Celtique Sa
A method of preparing pharmaceutical compositions by melt pelletisation

GB2288117A
(en)

1994-03-01
1995-10-11
Euro Celtique Sa
Sustained release morphine

US5968551A
(en)

1991-12-24
1999-10-19
Purdue Pharma L.P.
Orally administrable opioid formulations having extended duration of effect

GB2281204A
(en)

1993-07-27
1995-03-01
Euro Celtique Sa
Sustained release morphine compositions

US5478577A
(en)

1993-11-23
1995-12-26
Euroceltique, S.A.
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level

US5958459A
(en)

1991-12-24
1999-09-28
Purdue Pharma L.P.
Opioid formulations having extended controlled released

NZ260408A
(en)

1993-05-10
1996-05-28
Euro Celtique Sa
Controlled release preparation comprising tramadol

IL110014A
(en)

1993-07-01
1999-11-30
Euro Celtique Sa
Solid controlled-release oral dosage forms of opioid analgesics

US7740881B1
(en)

1993-07-01
2010-06-22
Purdue Pharma Lp
Method of treating humans with opioid formulations having extended controlled release

US5879705A
(en)

1993-07-27
1999-03-09
Euro-Celtique S.A.
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions

US5891471A
(en)

1993-11-23
1999-04-06
Euro-Celtique, S.A.
Pharmaceutical multiparticulates

KR100354702B1
(en)

1993-11-23
2002-12-28
유로-셀티크 소시에떼 아노뉨

Manufacturing method and sustained release composition of pharmaceutical composition

US5843480A
(en)

1994-03-14
1998-12-01
Euro-Celtique, S.A.
Controlled release diamorphine formulation

GB9422154D0
(en)

1994-11-03
1994-12-21
Euro Celtique Sa
Pharmaceutical compositions and method of producing the same

US5965161A
(en)

1994-11-04
1999-10-12
Euro-Celtique, S.A.
Extruded multi-particulates

US6806294B2
(en)

1998-10-15
2004-10-19
Euro-Celtique S.A.
Opioid analgesic

DE19918325A1
(en)

1999-04-22
2000-10-26
Euro Celtique Sa
Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives

US10179130B2
(en)

1999-10-29
2019-01-15
Purdue Pharma L.P.
Controlled release hydrocodone formulations

RU2230556C2
(en)

1999-10-29
2004-06-20
Эро-Селтик, С.А.
Hydrocodon preparative sustained-release formulations

EP2263658A1
(en)

2000-10-30
2010-12-22
Euro-Celtique S.A.
Controlled release hydrocodone formulations

UA81224C2
(en)

2001-05-02
2007-12-25
Euro Celtic S A
Dosage form of oxycodone and use thereof

US20110104214A1
(en)

2004-04-15
2011-05-05
Purdue Pharma L.P.
Once-a-day oxycodone formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3634584A
(en)

1969-02-13
1972-01-11
American Home Prod
Sustained action dosage form

CA1097220A
(en)

1975-10-10
1981-03-10
Aaron L. Weiss
Controlled release tablet

SU806037A1
(en)

1978-04-06
1981-02-23
Всесоюзный Кардиологический Научныйцентр Amh Cccp
Antianginal agent

DE2904310A1
(en)

1979-02-05
1980-08-07
Boehringer Mannheim Gmbh

MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF

GB2042888B
(en)

1979-03-05
1983-09-28
Teijin Ltd
Preparation for administration to the mucosa of the oral or nasal cavity

1983

1983-09-06
AU
AU18737/83A
patent/AU1873783A/en
not_active
Abandoned

1983-09-06
ZA
ZA836627A
patent/ZA836627B/en
unknown

1983-09-12
EP
EP83108974A
patent/EP0108218A3/en
not_active
Withdrawn

Cited By (4)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU581177B2
(en)

1983-05-31
1989-02-16
Choong-Gook Jang
Dry direct compression compositions for controlled release dosage forms

AU588630B2
(en)

1985-10-11
1989-09-21
Aktiebolaget Hassle
Pharmaceutical preparation with controlled release of metoprolol

AU597952B2
(en)

1986-04-17
1990-06-14
Alza Corporation
Chlorpheniramine therapy

US6022498A
(en)

1996-04-19
2000-02-08
Q2100, Inc.
Methods for eyeglass lens curing using ultraviolet light

Also Published As

Publication number
Publication date

EP0108218A2
(en)

1984-05-16

ZA836627B
(en)

1984-05-30

EP0108218A3
(en)

1984-11-28

Información de contacto